Loading...

Addition of Muramyl Tripeptide to Chemotherapy for Patients with Newly Diagnosed Metastatic Osteosarcoma: a Report from the Children's Oncology Group

BACKGROUND: The addition of liposomal muramyl tripeptide phosphatidylethanolamine (L-MTPPE) to chemotherapy has been shown to improve overall survival in patients with non-metastatic osteosarcoma (OS). We report the results of L-MTP-PE addition to chemotherapy for patients with metastatic OS. METHOD...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Chou, Alexander J., Kleinerman, Eugenie S., Krailo, Mark D., Chen, Zhengjia, Betcher, Donna L., Healey, John H., Conrad, Ernest U., Nieder, Michael L., Weiner, Michael A., Wells, Robert J., Womer, Richard B., Meyers, Paul A.
Format: Artigo
Sprog:Inglês
Udgivet: 2009
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2783515/
https://ncbi.nlm.nih.gov/pubmed/19637348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.24566
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!